CancerFax
GLOBAL TREATMENT ACCESS

COUNTRIES OFFERING ADVANCED
CANCER TREATMENT

A global comparison of where advanced cancer treatments are available โ€” costs, capabilities, and how to access them as an international patient.

analyticsAt a Glance

  • check_circleChina, India, South Korea, Germany, Israel, and Japan are leading destinations for advanced oncology care
  • check_circleChina leads in CAR-T trials, novel immunotherapy, and affordable advanced treatment access
  • check_circleIndia offers high-quality surgery, targeted therapy, and bone marrow transplant at lower cost
  • check_circleCancerFax helps patients compare countries and select the most appropriate destination for their case
Reviewed by: CancerFax Medical Team, Oncology & Haematology SpecialistsLast reviewed: April 16, 202610 min read

Advanced Cancer Treatment Is a Global Landscape

Cancer patients now have treatment options across multiple countries. Regulatory approvals, pricing, clinical trial access, and treatment expertise vary significantly by region.

โ€œThe best cancer treatment may not be in your home country โ€” global access changes the equation.โ€

Treatment Availability by Country

CountryCAR-TImmunotherapyTargeted TherapyClinical Trials
United States6 FDA-approved productsComprehensiveComprehensiveMost active globally
China4 NMPA-approved + 100+ trialsGrowing rapidlyWidely availableExtensive pipeline
European Union5 EMA-approved productsComprehensiveComprehensiveActive
IndiaClinical trials; domestic comingWidely availableWidely availableGrowing
South KoreaSelect productsAvailableAvailableActive
IsraelAvailableAdvancedAdvancedActive

CAR-T Treatment Cost by Country

Approximate all-in cost comparison for CAR-T therapy.

CAR-T All-In Cost (USD)

    Why China Has Emerged as a CAR-T Hub

    China has the second-largest CAR-T therapy pipeline globally.

    • 100+ Active CAR-T Trials

      China runs more CAR-T clinical trials than any country outside the US.

    • 60-80% Lower Cost

      Domestic manufacturing and competitive pricing make CAR-T accessible.

    • Faster Access

      Shorter wait times compared to US centers; manufacturing turnaround is faster.

    Frequently Asked Questions

    About International Treatment

      How CancerFax Helps

      CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.

      description
      Medical Record Review

      We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.

      verified_user
      Eligibility Coordination

      We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.

      hub
      Hospital Communication

      We support appointment coordination, document submission, translation, and direct communication with international departments.

      flight
      Travel & Admission Support

      For international patients, we help with practical coordination โ€” travel planning, hospital admission guidance, and local support.

      explore
      Treatment & Trial Navigation

      If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.

      support_agent
      End-to-end Coordination

      From inquiry through to follow-up, our coordinators provide a single point of contact for the family.

      CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.

      Looking for Cancer Treatment Options Abroad?

      Upload your reports and we will identify the best treatment options and locations worldwide for your specific cancer.

      This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.